rosiglitazone has been researched along with Leukemia, T-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, H; Hong, T; Wang, H; Wei, R; Yang, J; Yu, F | 1 |
1 other study(ies) available for rosiglitazone and Leukemia, T-Cell
Article | Year |
---|---|
Anti-proliferative effect of rosiglitazone in the human T-lymphocyte leukaemia cell line Jurkat cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Humans; Jurkat Cells; Leukemia, T-Cell; Metformin; PPAR gamma; Receptor, IGF Type 1; Receptor, Insulin; Receptors, Somatomedin; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2018 |